Episodit
-
Hold onto your antioxidants—this episode of the podcast is a full-court press on free radicals!
When it comes to the science of antioxidants and topical formulations, we have the right person-dermatologist Dr. Mark Lupin debuts as a faculty expert on the podcast to practically decipher what you NEED to know
Also debuting on the podcast, but as a guest co-host, is dermatologist Dr. Vincent Richer who's ready to fire up the hot seat with pharmacist Aaron Sihota to ask the tough questions.
Don’t miss our RAPID FIRE round where we break down must-know ingredients faster than you can say ‘free radical!’ 🚀🦸
We dust off your old sunscreen routine and show you why slathering on antioxidants might just be your skin’s new secret weapon. Tune in for a fast-paced conversation that hops effortlessly from clinic chairs to concert halls, apples to ferulic acid, and vitamin C to conjugated retinol. Here, myths get busted, fancy science terms get decoded, and you’ll finally learn the ABCs of a top-tier skincare regimen—no sunscreen-shy patients or lost winter gloves required. ☀️🧴🍏
Trust us, this episode is your on-demand playbook reference for practice! 🎧📖
Learning Objectives:
Antioxidant Fundamentals: Understand how environmental aggressors cause oxidative stress on the skin and how antioxidants serve as powerful defenders. The latest science on how these mighty molecules supercharge your broad-spectrum sunscreen and reduce UV-induced damage?🌞🔬 🍃Key Ingredients in formulations: Identify evidence-based antioxidant ingredients, learn why they’re paired together, and explore optimal formulation concentrations and pH levels for maximum skin benefits. 🍏🔬Critical Evaluation of Research: Gain tools and strategies to discern credible studies from marketing fluff, ensuring more informed clinical recommendations. 📚🔎Integration into Practice: Discover practical tips for incorporating antioxidants into morning routines, combining them effectively with sunscreens, and managing patient expectations. ⏰✔️Future Directions in Dermatology: Explore the promising frontier of antioxidant research, including their potential to complement medical interventions and the call for standardized validation measures. 🔭🚀Get ready for an antioxidant masterclass 🤓✨— that’ll have you completely rethinking your recommendations!
ABOUT DR.MARK LUPIN MD FRCPC DABD
VICTORIA, BC
Dr. Lupin is a Board-certified Dermatologist, Founder in 1998 of Cosmedica Laser Centre in Victoria, British Columbia and Chief Clinical Officer of MedSpa Partners Inc.He has degrees in Mathematics, Music and Medicine having studied at the University of Toronto, University of British Columbia, Dalhousie University, Indiana University and the University of Southern California. He has special interests in photodermatology and laser medicine, having studied under Professor John Hawk at St John’s Institute of Dermatology, London, England. He is active with research and education, has additional subspecialty training in Neurology and is past President of the Canadian Laser Aesthetic Surgery Society.
As a concert violinist, Dr Lupin has performed as soloist at Carnegie Hall, New York and with major orchestras around the world. He is Concertmaster of the World Doctors Orchestra (WDO), performing most recently in Australia at the Sydney Opera House, with all proceeds donated to charities. His research interests extend to space medicine and fluid dynamics where he has been active with mathematical modeling for space tools and has developed several patent pending energy efficient devices.
ABOUT Dr. Vincent Richer MD FRCPC
VANCOUVER, BC
Dr Vincent Richer practices cosmetic dermatology at Pacific Derm Atelier in Vancouver and holds a position as Clinical Assistant Professor at the University of British Columbia’s Department of Dermatology and Skin Science. He trained at Université de Montréal in Medicine and Dermatology and completed a fellowship in Photobiology and Cutaneous Laser Surgery at UBC. He is involved as a subinvestigator in cosmetic clinical trials, has published 35+ peer reviewed scientific articles and is active in undergraduate, graduate and continuing medical education.
EPISODE SUPPORTED BY SKINCEUTICALS AND SKINBETTER SCIENCE.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
Unlocking the Secrets of Clear Skin (and Soggy Shoes) in Amsterdam! 🌧️👟✨
Ready to revolutionize your approach to atopic dermatitis? 🤔
Join us on the latest episode of the Skin and Joints podcast, live from the EADV in Amsterdam! 🇳🇱
Dr. Marissa Joseph and Dr. Max Sauder, braved the Dutch downpours to bring you exclusive insights into lebrikizumab—the new kid on the block that's making waves 🌊 in eczema treatment.
Discover how this IL-13 inhibitor is changing the game 🎯 with its long-term efficacy, flexible dosing schedules, and impressive safety profile. 📊 We'll dive deep into the ADJOIN study's three-year data, discuss where lebrikizumab fits into the current treatment landscape for their respective practices 🩺, and explore how it could be a game-changer for your patients..
🗺️Get a taste of our guests' Amsterdam adventures—from waterlogged wanderings 🚶♀️🌧️ to culinary delights 🍽️ Plus, find out why Max might be shopping for a princess dress 👗 before the next conference 🏰🎢
🎙️ Tune in and get ready to see atopic dermatitis treatment in a whole new light! 💡
Learning Objectives:
Understand the mechanism of action of lebrikizumab in treating atopic dermatitis, focusing on its role as an IL-13 inhibitor 🧬.Analyze the long-term efficacy and safety data from the ADjoin study, emphasizing the durability of lebrikizumab over a three-year period 📈.Compare the dosing regimens (biweekly vs. monthly) of lebrikizumab and their implications for patient adherence and treatment outcomes 📆.Evaluate how lebrikizumab fits into current clinical practice for atopic dermatitis, considering patient preferences and the spectrum of available therapies 🩺.Recognize the importance of expanding therapeutic options in atopic dermatitis management and how to personalized patient care 🎯.ABOUT DR.MARISSA JOSEPH
Dermatologist, Toronto, ON
Marissa Joseph, MSc, MD, FRCPC ( Pediatrics), FRCPC ( Dermatology)
Dr. Marissa Joseph is a board certified Pediatrician and Dermatologist after completing Pediatric training at the Hospital For Sick Children, following with a Dermatology residency at the University of Toronto. She completed a MSc in Community Health at the Dalla Lana School of Public Health.
Dr. Joseph is full time academic faculty at the Unee Schachter Dermatology Centre at Women's College Hospital. She also works at the Hospital For Sick Children where she manages children with complex dermatologic disease in outpatient and inpatient settings, as well as a pediatric laser treatment program. Dr. Joseph enjoys her diverse practice in general adult, pediatric and surgical dermatology. Her clinical and research interests include inflammatory skin disorders such as psoriasis, atopic dermatitis, and hidradenitis suppurativersity of Toronto. She has received and has been nominated for teaching awards in both undergraduate and postgraduate medical education. Dr. Joseph is the Medical Director of the Ricky Kaniva; genodermatoses, and equity, diversity and inclusivity.
About Dr.Maxwell Sauder MD, FRCPCDermatologist | TorontoDr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.
Dr. Sauder is currently an assistant professor at the University of Toronto. He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.
Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partner’s President Prize at Harvard and the Royal College’s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.
Epsode supported by an Independent Medical Educational Grant from Lilly.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
Puuttuva jakso?
-
🚴♀️ Biking and the Battle Against Itch! 🎙️
Live from the charming canals of Amsterdam at the EADV 2024 meeting, we sit down with the ever-energetic Dr. Perla Lansang from Toronto!
🍁 She's ditched cabs and metros to embrace the Dutch biking culture, even bringing her own bike across the pond! 🚲🌍 From navigating streets with more bikes than people 😲 to packing rain ponchos for unpredictable weather ☔, Dr. Lansang shares her love for the city.
🍽️ She's on a mission to find the best delectable mini Dutch pancakes topped with butter and powdered sugar 🥞✨. And while we couldn't coax the secret behind her infamous kale smoothie 🥬🥤, we dive into something even more exciting.
We explore late breaking fresh new data presented at EADV on nemolizumab, the new therapeutic targeting IL-31 that's set to revolutionize atopic dermatitis treatment! What does this new 56-week data from an interim analysis of the phase III ARCADIA long-term extension study mean for your patients?
🧪🔥 Discover how this game-changing drug offers rapid itch relief—some patients feel better in just days! 😮🧖♂️
We'll unpack nemolizumab’s long-term efficacy and safety in atopic dermatitis, discuss the stellar safety profile, and delve into how it is poised to transform patient care by improving sleep 😴 and overall quality of life 🌟.
This episode is packed with laughs 😂, insightful clinical pearls 🩺, and a sprinkle of Dutch delight! 🎧🌷
Learning Objectives:
Understand the pivotal role of IL-31 in atopic dermatitis and why nemolizumab's targeting of this cytokine is a breakthrough.Review the design, key findings, and clinical significance of the Arcadia 1 and 2 long-term extension data up to 56 weeks.Discuss the rapid efficacy and excellent safety profile of nemolizumab and its impact on itch relief, clearance and patient adherence.Evaluate the clinical implications of integrating nemolizumab into practice and its potential to transform atopic dermatitis management.ABOUT Dr. Perla Lansang, MD, FRCPC ( Dermatology)
Toronto, ON
Dr. Perla Lansang is a full-time staff dermatologist and associate professor in the Division of Dermatology, University of Toronto where she is the Division Head of Dermatology at Sunnybrook Health Sciences Centre. She is also cross appointed at the Section of Paediatric Dermatology at the Hospital for Sick Children, and the Division of Obstetric Medicine at Sunnybrook Health Sciences Centre.
She completed her medical school and dermatology residency at the University of the Philippines-Philippine General Hospital. Having done fellowships in paediatric dermatology at The Hospital for Sick Children and in advanced medical dermatology at Sunnybrook Health Sciences Centre, Dr. Lansang’s practice is a mixture of pediatric, adolescent, and adult dermatology, with a special focus on psoriasis, atopic dermatitis, cutaneous lymphoma, pregnancy dermatoses, and general medical dermatology. She has a special interest in immune-mediated skin diseases and has extensive clinical and research experience in many areas of immunodermatology.📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🎙 Amsterdam Stories, Delta Force & A Game-Changing Topical for Chronic Hand Eczema
🎉✨ Melinda Knows Best is BACK! 🚀💥
This time, Dr. Gooderham brings us a heavyweight showdown 🥊 between a new topical superhero 🦸♀️ and the reigning oral champ 💊 in the battle against Chronic Hand Eczema! reporting live from the European Academy of Dermatology and Venereology (EADV) Congress in the beautiful city of Amsterdam! 🇳🇱✨
In this special episode, we’re diving into the Delta Force Trial – a bold study comparing topical delgocitinib to oral alitretinoin for chronic hand eczema 💊🧴
👀 Dr. Gooderham spills the beans on impressive results, rapid relief, and how this new treatment is about to change the game for dermatologists and patients alike. 🎉
Oh, and don’t worry, we didn’t forget to ask about her Amsterdam adventures! 🌍 Did she run into some famous faces at dinner? 🍽️👀 Tune in for the scoop!
💡 Melinda Knows Best will keep you at the cutting edge of CHE breakthroughs. 👩⚕️✨
🎯 Learning Objectives:
Explore the Delta Force Trial Findings: Understand the significance of the Delta Force trial comparing topical delgocitinib to oral alitretinoin for chronic hand eczema. 🧴💊Evaluate the Efficacy of Topicals vs Orals for chronic hand eczema: Learn about the early onset of symptom relief with delgocitinib, including i reductions in HEXI scores and patient quality of life improvements. ⏱️📉Identify Key Real-World Implications: Discuss how this new topical treatment can shift the landscape for clinicians and patients, offering rapid, safe relief without the headaches (literally!) of oral therapies. 💡 Dive into secondary endpoints, including itch and pain relief, and how this data compares to other major clinical trials in hand eczema treatment. 📊🔬ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)
Toronto, ON
Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🎙️ Skin Joins Podcast Wrap-Up: Sunny Stories & Cool Pools 🌞
We welcome back Dr. Michele Ramien, who graced our podcast last July from the sunny World Congress of Dermatology in Singapore. 🌏 Fast forward, she reflects on dermatology innovation from vibrant city of San Diego! 🌴
Dr. Ramien shares a delightful (and chilly) San Diego story about renting a house wit, a freezing-cold pool, and a group of eager people determined to swim🏊♂️❄️
We deep dive into the exciting highlights from the American Academy of Dermatology conference. Dr. Ramien, attending AAD for the first time in a while, reveals fascinating pearls and🩺✨ innovative treatments including the potential for disease remission in young patients, as well as fresh new insights on melasma and post-inflammatory hyperpigmentation in Asian skin 🌟
Dr. Ramien also touches on the importance of adapting treatments for different skin types and the promising future of pediatric dermatology. 👶💡
Learning Objectives:
🌍 Understand the global advancements in dermatology from the AAD conference.🧴 Learn about innovative treatments for atopic dermatitis, including pediatric applications.🎨 Explore the management of melasma and post-inflammatory hyperpigmentation in diverse skin types.🧒 Discover the potential for disease remission in young patients with early and targeted treatments.Tune in for a blend of personal stories, professional insights, and a sneak peek into the future of dermatological treatments. 📚🔍
Stay tuned, stay informed, and as always, keep your skin happy 🌟🧴
Supported by an IME Grant from Pfizer
ABOUT Dr. Michele L. Ramien
Pediatric Dermatologist | Calgary
Dr. Michele Ramien is an academic dermatologist based at the Alberta Children’s Hospital, in the foothills of the Rocky Mountains in Calgary, Canada. She has both pediatric and general medical dermatology practices, with a focus on teaching and mentoring the next generations and research interests in eczema management, patient education, and severe cutaneous reactions in children.
Dr. Ramien enjoys volunteer leadership positions as a way to meet colleagues across the country, like-minded and not, who believe that a small group of thoughtful, committed individuals can change and improve dermatology and delivery of care in Canada.
📻www.skinandjoints.ca
-
🎙️ More than Skin Deep Insights with Dr. Lauren Lam!🎙️
👩⚕️💬 As we get close to wrapping up our coverage of AAD 2024, get ready as we welcome back Dr. Lauren Lam. We dive deep into her recent experience at the AAD in sunny San Diego. 🌞🏖️
Learning Objectives:
🧠 Understand the practical applications of translational medicine in dermatology, particularly in treating chronic skin conditions.🛠️ Identify key clinical pearls and advancements in dermatology that can be immediately implemented in practice to improve patient care.What’s on the agenda for this mini-podcast drop?
🌟 San Diego Stories: From bar hopping in a Japanese-themed spot 🌸🍹 to pelican watching at the pier 🦩📸, Lauren shares her unique experiences and the vibrant cultural mix that San Diego offers.🔍 Translational Medicine Takeaways: Discover how the latest advancements in bench-to-bedside research are transforming dermatological practices. 🧬🩺💡 Clinical Pearls Galore:Hidradenitis Suppurativa Insights: Understand why de-roofing is essential even with biologics 🩹🔬.Alopecia Areata Breakthroughs: Learn about the impact of JAK inhibitors 🧑🦲➡️🧑🦰.Pyoderma Gangrenosum Progress: Hear about the promising results of IL-36 inhibitors in treating this challenging condition 💉🌟.Join us for a lively episode that blends professional insights with personal anecdotes, and don't miss out on the laughter and wisdom Dr. Lam brings to the table 🎧✨
ABOUT Dr. Lauren Lam
Dermatologist | Calgary
Dr. Lauren Lam is a Canadian & American board-certified dermatologist. She is a native Calgarian who completed her medical school training at the University of Calgary & her dermatology residency at the University of Alberta. Since graduating, Dr. Lam has become a Clinical Lecturer with the University of Alberta. Her particular passions in dermatology are acne & hidradenitis suppurativa deroofings. In addition to her regular practice, she volunteers on overseas medical trips. Her passion for providing care for under-served populations has taken her to Nunavut & rural Fiji. Outside of medicine, Dr. Lam is a proud aunt to 4 dogs, culinary enthusiast & international explorer.
📻www.skinandjoints.ca
-
🎙️ My CASMO (Canadian Skin Management in Oncology) Playbook: Part 2🎙️
Description:
In Part 2, dermooncologist Dr. Max Sauder returns to delve deeper into the CASMO algorithm. We navigate the complexities of managing severe cutaneous reactions in patients undergoing radiation. From identifying critical symptoms that necessitate urgent care to understanding the nuances of radiation dermatitis stages and risk factors, this episode is packed with expert insights and practical advice. We focus on 2 specific areas:
Assessment and Severity Evaluation: Guidance on evaluating the severity of skin toxicities, incorporating case studies to illustrate practical approaches.Management Protocols: Exploration of practical management strategies and specific interventions for common skin toxicities, drawing on literature evidence and expert consensus.Learning Objectives:
Identify Critical Symptoms:
Recognize severe cutaneous adverse reactions and understand when urgent care is necessary based on symptoms like fever, skin pain, blisters, mucous membrane involvement, and abnormal labs. 🚨Understand Radiation Dermatitis:
Differentiate between acute and chronic radiation dermatitis.Learn the grading systems (CTCAE and RTOG) and their simplified applications in the CASMO algorithm. 📊How to Manage Radiation Dermatitis:
Implement effective treatment strategies for both dry and moist desquamation.Understand the role of topical steroids and topical over-the-counter dos and don’ts💊Recognize Risk Factors:
Identify the factors that increase the risk of radiation dermatitis, considering the cancer type, radiation modality, and regimen. 🧬Learn to manage photosensitivity reactions, particularly with targeted therapies.Explore strategies to ensure patient adherence to prescribed skincare and sun protection protocols, emphasizing the importance of these measures in minimizing treatment interruptions. 🛡️Photosensitivity Reactions:
Understand the importance of proactive sun protection and the role of topical treatments. ☀️Promote Adherence:
Explore strategies to ensure patient adherence to prescribed skincare and sun protection protocols, emphasizing the importance of these measures in minimizing treatment interruptions. 🛡️Episode Highlights:
Danger Zone: Learn to identify those serious skin reactions that need urgent care, stat! 🌡️Radiation Dermatitis Deep Dive: Understand the stages and treatment of radiation dermatitis without getting lost in the weeds. 📋Risk Factors Unmasked: Get to know the usual suspects behind radiation dermatitis. 🔬Photosensitivity Savvy: Protect patients from those sneaky photosensitivity reactions with top-notch tips. 🌞Adherence Hacks: Keep patients sticking to their skincare and sun protection routines like glue. 🔄Join us for a discussion perfect for a quick listen on your commute or work out🎧
REFERENCES AND FURTHER RESOURCES:
1. The role of skin care in oncology patients: STL-Supp-SkinCareOnc-v2-correction.pdf (skintherapyletter.com)
2. Canadian general algorithm (cleanse, moisturize, protect):Canadian Skin Management in Oncology (CaSMO) Algorithm for Patients with Oncology Treatment-Related Skin Toxicities (skintherapyletter.com)
3. Canadian radiotherapy algorithm:Canadian Skin Management in Oncology Group (Casmo) Algorithm for the Prevention and Management of Acute Radiation Dermatitis (skintherapyletter.com)
4. Canadian immunotherapy algorithm: CaSMO Management of Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: A Practical Primer (skintherapyletter.com)
5. Canadian hormonal therapy algorithm: Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in Oncology Patients (skintherapyletter.com)
6. Canadian targeted therapy algorithm:Casmo Prevention and Management of Four Common Cutaneous Toxicities Associated with Targeted Cancer Therapies: Papulopustular Eruption, Xerosis, Paronychia, and Hand-Foot Skin Reaction (skintherapyletter.com)
About Dr.Maxwell Sauder MD, FRCPCDermatologist | Toronto
Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.
Dr. Sauder is currently an assistant professor at the University of Toronto. He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.
Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partner’s President Prize at Harvard and the Royal College’s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🌞🎧Dermatologist Dr.Max Sauder joins us and navigates us through the complexities of modern dermatological care💡
🎙️ My CASMO (Canadian Skin Management in Oncology) Playbook: Part 1🎙️
Get ready for a laugh and learn session as Dr. Jessica Asgarpour takes the co-hosting hot seat! This episode, we’re diving headfirst into the CASMO project with dermo-oncologist Dr. Max Sauder. We’ll decode the CASMO algorithm, tackle the nitty-gritty of managing skin toxicities, and even uncover Dr. Sauder's secret summer plans. Buckle up! 🎢
We're peeling back the layers of the CASMO project, an innovative approach to managing skin toxicities in cancer treatment. Can certain skin toxicities be prevented in patients? Is there a proactive skincare regimen that can be recommended?
Introduction to CaSMO and Skin Toxicities in Cancer Treatment: Overview of the significance of managing skin toxicities, introducing the CaSMO algorithm's development and objectives.Prevention Strategies: Detailed discussion on general skincare measures recommended by CaSMO, including the rationale behind the use of cleansers and moisturizers to maintain skin hydration and integrity.Episode Learning Objectives:
Understand the CASMO algorithm and its role in managing skin toxicities associated with cancer treatments.Recognize the importance of a multidisciplinary approach in improving patient outcomes.Identify practical proactive strategies for preventing and managing skin toxicities.Learn about the impact of skin toxicities on patients' quality of life and how to address these issues.Explore the role of various healthcare providers, including oncologists, nurses, and pharmacists, in supporting patients through their cancer journey.Press play for a dose of dermatological delight 🎙️✨
Episode supported by an IME Grant from LA ROCHE POSAY
REFERENCES AND FURTHER RESOURCES:
1. The role of skin care in oncology patients: STL-Supp-SkinCareOnc-v2-correction.pdf (skintherapyletter.com)
2. Canadian general algorithm (cleanse, moisturize, protect):Canadian Skin Management in Oncology (CaSMO) Algorithm for Patients with Oncology Treatment-Related Skin Toxicities (skintherapyletter.com)
3. Canadian radiotherapy algorithm:Canadian Skin Management in Oncology Group (Casmo) Algorithm for the Prevention and Management of Acute Radiation Dermatitis (skintherapyletter.com)
4. Canadian immunotherapy algorithm: CaSMO Management of Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: A Practical Primer (skintherapyletter.com)
5. Canadian hormonal therapy algorithm: Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in Oncology Patients (skintherapyletter.com)
6. Canadian targeted therapy algorithm:Casmo Prevention and Management of Four Common Cutaneous Toxicities Associated with Targeted Cancer Therapies: Papulopustular Eruption, Xerosis, Paronychia, and Hand-Foot Skin Reaction (skintherapyletter.com)
About Dr.Maxwell Sauder MD, FRCPCDermatologist | Toronto
Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.
Dr. Sauder is currently an assistant professor at the University of Toronto. He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.
Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partner’s President Prize at Harvard and the Royal College’s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🎙️ Melinda Knows Best at the AAD! 🌟
We’ve got a special LATEBREAKER episode for you, continuing our coverage from the American Academy of Dermatology in San Diego!
👟💡 Pro Tip: Don't miss Dr. Gooderham’s advice on navigating massive convention centers in style and comfort!
We dive into the highly anticipated Delta 3 study, shedding light on long-term safety and efficacy of Delgocitinib cream for Chronic Hand Eczema.
Subjects who completed the 16-week treatment period in one of the parent trials DELTA 1 and DELTA 2 were treated with twice daily delgocitinib cream as needed to control their chronic hand eczema for 36 weeks.Practical Tips for Dermatology Practices 🏥💼
Adapting treatment plans for chronic hand eczema.Benefits of as-needed treatment approaches for better patient outcomes.Dr. Gooderham’s Conference Adventures 🛫👩⚕️👨⚕️
Dr. Gooderham also shares her intriguing encounters from Toronto to San Diego, including a surprise meeting with April Armstrong and an old friend from med school. 🛫Episode Learning Objectives:
Understand the primary and secondary endpoints of the Delta 3 study and its implications for treating chronic hand eczema.Learn about the safety profile of Delgocitinib cream and its significance in long-term treatment plans.Gain insights into real-world application of delgocitinib and patient adherence strategies for topical treatmentsLace up those sneakers, grab a protein bar, and join us for a walk through the latest dermatological advancements! 🥾🍫
🎙️ Melinda Knows Best at the AAD – where expert insights meet real-world application (pun intended)📍📍
Episode supported by an IME Grant from LEO Pharma
ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)
Dermatologist | Toronto
Toronto, ON
Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.
References
Gooderham M. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA 3 trial. Presented at: 2024 American Academy of Dermatology Annual Meeting; March 8-12, 2024; San Diego, CA.📻www.skinandjoints.ca
-
🎙️🌞 Tight Spaces & Hair-Raising Breakthroughs – Live from AAD San Diego! 🎙️🌴
Join Skin and Joints Podcast AAD Guest Faculty and Vancouver based dermatologist, Dr,Diana Diao, as she navigates the cramped quarters of a historic boutique hotel in the Gaslamp Quarter—tiny rooms, weird noises, and all! 🏨😅
Dr. Diao explore groundbreaking sessions on alopecia areata, revealing innovative treatments and valuable clinical insights that are shaping the future of dermatology.
🌟💊Don't miss out on Dr. Diao's top clinical takeaways that could revolutionize treatment approaches for dermatologists everywhere. Whether it's systemic therapies for extensive scalp involvement or tailored treatments for unique patient profiles, this episode is packed with insights that promise to enhance patient care.
💬 Tune in, transform your approach with pearls that could change your practice overnight!
🎧✨ #SkinJointsPodcast #DermatologyInDepth
Learning Objectives:
Gain Insight into New Treatments for Alopecia Areata: Learn about the latest advancements and clinical trials discussed at AAD, including newly approved treatments and their application in real world practice.Appreciate the Psychosocial Aspects of Dermatological Conditions: Recognize the significant emotional and social challenges faced by patients with alopecia areata and the importance of addressing these in real world practice.Implement Clinical Pearls in Practice: Discover actionable tips and strategies that can be immediately applied to improve patient outcomes.#SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSun
Episode supported by an IME Grant from Pfizer and Bausch Health.
ABOUT DR. DIANA DIAO FRCPC, FAAD
Dermatologist | Vancouver, BCDr. Diana Diao is a Dermatologist and a Clinical Instructor in the Department of Dermatology and Skin Science at the University of British Columbia. She is a consultant dermatologist at both Vancouver General Hospital and St. Paul’s Hospital. Dr. Diao practices medical and procedural dermatology, with a special interest in using energy-based modalities such as lasers to treat a variety of skin conditions.
Dr. Diao completed both her Medical Doctorate degree and dermatology residency training at the University of British Columbia, and is a Fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Diao is a mother, a published author, and has presented her work at conferences such as the World Congress of Dermatology and the American Academy of Dermatology meetings. Dr. Diao is also fluent in Mandarin.
📻www.skinandjoints.ca
-
🎙️🌞 An AAD 2024 Coles Notes Deep Dive – Welcome to a potpourri episode of the Skin and Joints Podcast, streaming from the vibrant city of San Diego.
Join us as we sit down with Guest Faculty dermatologist expert the much-anticipated Dr. Mark Kirchhoff, whose voice is as deep and profound as his insights into dermatology. 🎤💬
Medical Innovations Uncovered:
• Key Sessions from AAD: We traverse the entire meeting with key insights into s🎙️🌞 An AAD 2024 Coles Notes Deep Dive – Welcome to a potpourri episode of the Skin and Joints Podcast, streaming from the vibrant city of San Diego.
Join us as we sit down with Guest Faculty dermatologist expert the much-anticipated Dr. Mark Kirchhoff, whose voice is as deep and profound as his insights into dermatology. 🎤💬
Medical Innovations Uncovered:
• Key Sessions from AAD: We traverse the entire meeting with key insights into significant advancements, focusing on HS, AD, PsO and AA.
• Late Breaker Highlights: An overview of the most cutting-edge studies presented, including potential new therapies and their implications for future treatment protocols including rethinking long term disease remission to the exploration of new and novel therapeutic targets.
Learning Objectives:
Delve into Dermatological Innovations: Get the latest updates on groundbreaking treatments for HS, AA, AD and PsO as well as other skin conditions from the AAD meeting. 🔬💡Discuss Future Directions in Dermatology: Examine the potential shifts in treatment approaches and how they align with current patient needs and future therapeutic strategies. 🌟Dr. Kirchhoff also reflects on the changing landscape of medical conferences influenced by social media and digital dissemination of knowledge
Join us for a blend of professional insights and personal anecdotes that promise to educate and entertain. Tune in to catch Dr. Kirchhoff’s voice and vision for the future of dermatology! 📚🎧
#SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSun
Episode supported by an IME Grant from Pfizer and Bausch Health.
ABOUT DR. MARK KIRCHHOF,MD, PHD, FRCPC, FAAD
Dermatologist | Ottawa, ONDr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.
Until August 2017, Dr. Kirchhof was the Education Director at Queen’s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 40 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.ignificant advancements, focusing on HS, AD, PsO and AA.
• Late Breaker Highlights: An overview of the most cutting-edge studies presented, including potential new therapies and their implications for future treatment protocols including rethinking long term disease remission to the exploration of new and novel therapeutic targets.
Learning Objectives:
Delve into Dermatological Innovations: Get the latest updates on groundbreaking treatments for HS, AA, AD and PsO as well as other skin conditions from the AAD meeting. 🔬💡Discuss Future Directions in Dermatology: Examine the potential shifts in treatment approaches and how they align with current patient needs and future therapeutic strategies. 🌟Dr. Kirchhoff also reflects on the changing landscape of medical conferences influenced by social media and digital dissemination of knowledge
Join us for a blend of professional insights and personal anecdotes that promise to educate and entertain. Tune in to catch Dr. Kirchhoff’s voice and vision for the future of dermatology! 📚🎧
#SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSun
Episode supported by an IME Grant from Pfizer and Bausch Health.
ABOUT DR. MARK KIRCHHOF,MD, PHD, FRCPC, FAAD
Dermatologist | Ottawa, ONDr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.
Until August 2017, Dr. Kirchhof was the Education Director at Queen’s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 40 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.
📻www.skinandjoints.ca
-
🌍✨ Welcome to a US-Canada Acne Dialogue Where we Unpack the Art of Acne Treatment Customization and Master Practical Clinical Pearls.🎙️🍁🇺🇸
🌉🔬Skin and Joints Podcast Faculty Dermatologist duo, Dr.Linda Stein Gold and Dr. Mimi Tran, converge to unravel a MasterClass on the latest in acne management, distilled straight from the AAD with a focus on defining the role and place of a new topical hormonal anti-androgen agent and why all isotretinoin options are not the same 🌞
🎯Learning Objectives:
Advances in Acne Care Innovation: Gain practical insights into the newly released AAD acne guidelines, how they should be used for the patient in front of you, straight from one of the Faculty members that helped create it! Dr.Stein Gold deep dives into the critical balance between guideline recommendations and the nuanced needs of individual patients, highlighting the importance of cost considerations, treatment efficacy, and the patient-practitioner partnership in dermatology.Dive into the world of new acne therapies, including the groundbreaking topical androgen receptor blocker and its role in reducing sebum production. A leap forward in topical acne treatment! 🆕💡Beyond the Surface: Learn about the significance of vehicle design in topical medications — a crucial factor for efficacy, tolerability, and patient satisfaction. It's not just what's inside that counts, but how it's delivered. 🚚💊The Isotretinoin Evolution: Explore the latest advancements in isotretinoin formulations that promise enhanced absorption without the need for fatty meals, paving the way for more effective and flexible treatment options. 🍽️➡️💧Empowering Patients: Embrace the power of visual progress tracking with baseline and follow-up photographs, fostering patient engagement and adherence. A picture is worth a thousand words, especially in acne treatment! 📸📈🌟 Stay tuned
#HealthcareCrossroads #AcneInnovation #USCanadaConnection 🎧💬
EPISODE Supported by SUN Pharma
Dr.Linda F Stein Gold, MD, FAADDermatologist, Detroit, MI
Linda Stein Gold, MD, is Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, Michigan, as well as Division Head of Dermatology at Henry Ford Health System in West Bloomfield, Michigan.
Dr. Stein Gold earned her undergraduate degree at the Wharton School of the University of Pennsylvania and her medical degree from the University Of Pennsylvania School Of Medicine in Philadelphia and completed her residency in dermatology at Henry Ford Hospital in Detroit.
Dr. Stein Gold is very active in clinical research on a variety of dermatologic conditions, including the treatment of chronic plaque-type psoriasis, actinic keratosis, atopic dermatitis, acne vulgaris, seborrheic dermatitis, and rosacea. She has published articles in journals such as the Journal of the American Academy of Dermatology, Cutis, the Journal of Drugs in Dermatology among others. She is a frequent national and international lecturer on acne, rosacea, psoriasis, actinic keratosis, alopecia, viral infections, atopic dermatitis, and fungal infections, at grand rounds and medical society meetings. She is also the treasurer of the National Acne and Rosacea Society and a member of the National Psoriasis Foundation Medical Board.
Dr. Mimi Tran MD, FRCPCDermatologist, Winnipeg, MB
Dr Mimi Tran is a dual board-certified Dermatologist in Canada and the USA. After graduating from medical school at the University of Calgary, she pursued a rigorous Dermatology residency at the University of British Columbia. She has trained in centres across Canada. With her extensive experience from practicing in Vancouver, Dr Tran decided to bring her exceptional skills and expertise back to her hometown of Winnipeg. Dr. Tran practices in both Medical and Cosmetic Dermatology. She has a particular interest in Skin Cancer, Acne, Eczema, Psoriasis, as well as Cosmetic Dermatology.
📻www.skinandjoints.ca
-
🌞🎙️ Live from AAD 2024 in San Diego!🎙️🌞
We're bringing you the freshest insights straight from the sun-kissed halls of the AAD 2024 conference in San Diego. 🌴✨ With the iconic Hard Rock Hotel glittering in the back, we dive deep into the world of acne - and oh boy, do we have some groundbreaking news for you! 🧴💥
🤩 Joining us are our guest Faculty tag team from Toronto who share their pearls of wisdom under the California sun. We're buzzing about the latest in acne attack plans, especially the shiny new AAD guidelines dropped like a hot potato at the end of January. 📜🔍
🧪 From the comforting confirmation of our daily dermatological dos to the intriguing nods towards affordability and access - this episode is packed! 🎉 We navigate through the sea of sessions to spotlight the crème de la crème on acne management. 🚀
Understand the 2024 Acne Guidelines: Gain a comprehensive understanding of the new AD acne guidelines released in January 2024, including their recommendations for the management of acne with topical antibiotics, retinoids, benzoyl peroxides, and the strategic use of oral therapies .Discuss the Impact of Drug Pricing: Delve into the discussion around how drug pricing influences the listing of therapies as first, second, or third line in the guidelines, and consider the implications of this from both U.S. and Canadian perspectives.Consider New and Emerging Therapies: Identify and evaluate new and emerging therapies in acne treatment, including the anticipation of new triple combination therapies and the introduction of clascotarone, highlighting their alignment with guideline recommendations for combination therapiesAddress the BPO Controversy:And just when you thought it couldn't get more exciting, we unboxed the potential of emerging therapies and dived into the benzene buzz surrounding benzoyl peroxide and how to counsel patients on these issues.Here's to clearer skies and even clearer skin ahead! 🌈👩⚕️👨⚕️ #AAD2024 #AcneAwareness #DermatologyDeepDive
EPISODE Supported by BAUSCH Health.
About Dr. Sam Hanna, FAAD, DABDDermatologist, Toronto, ON
Dr. Sam Hanna is at the forefront of innovation in cosmetic dermatology and is passionate about improving patient skin health with laser treatments, light treatments, and injectable solutions. Dr. Hanna specializes in achieving natural-looking outcomes by way of a holistic approach to cosmetic medicine. A board certified dermatologist and recognized expert in the use of cosmetic injectables including fillers, neuromodulators and sodium deoxycholate, Dr. Hanna is regularly called upon to share his expertise with physician colleagues in lectures and hands-on-training courses. He also lectures on a variety of issues such as dermatology workforce and skin disease treatments.
Dr. Hanna is the Medical Director at Dermatology On Bloor as well as a Diplomate of the American Board of Dermatology. He travels the world sharing his expertise and insights with the global medical and dermatology community.
Dr. Hanna was one of the first Dermatologists in Canada who was trained and certified to offer the Vacuum-Assisted Cellulite Band Release procedure for treatment of cellulite on the thighs and buttocks.
An active clinical trialist, Dr. Hanna has served as a principal investigator for numerous cosmetic & medical clinical trials with Probity Medical Research.
About Dr.Jessica Asgarpour, MD, FRCPC Dermatologist | Toronto, ON
Dr. Jessica Asgarpour is a Canadian and American board-certified dermatologist.She practices medical, surgical and cosmetic dermatology with a special interest in hidradenitis suppurativa, eczema, acne, psoriasis, and women’s health. She is currently working at Canadian Dermatology Centre and is also a clinical associate at Women’s College Hospital. She is a lecturer at University of Toronto and an active sub-investigator for ongoing clinical trials.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🌞🔍 Photoprotection in Skin of Colour: The Role of Visible Light and New Perspectives on Sun Protection
Episode Sneak Peek:
🤔 Debunking Myths: Think all skin reacts the same under the sun? Think again! We’re tackling 3 big misconceptions about photodamage across the Fitzpatrick Skin Types.Hot Seat Confessions: Our panel of dermatologist experts faces the heat 🔥, answering burning questions:
Is photodamage consistent across all skin colors?Can melanin alone ward off the sun’s advances?Do broad-spectrum sunscreens offer the ultimate armor against all sunlight villains?🌿💡Antioxidants: The Hype or Hero? We dissect the buzz around antioxidants in sunscreens – are they just a marketing myth or a must-have in your skincare arsenal?
🌞🧴 And yes, don’t forget your sunscreen, no matter your shade!
Episode Learning Objectives
Identify and correct misconceptions regarding the significance of photoprotection across different populations with a focus on darker skin phenotypes.Understand the detrimental effects of visible light on skin health.Explore the function of Reactive Oxygen Species (ROS) and antioxidants in sunscreen formulations.Apply tailored photoprotection regimens for individuals of all Fitzpatrick Skin Types (FSTs)#SkinAndJointsPodcast #ShadesOfBrown #BeyondLabels #SunProtectionForAll
EPISODE Supported by EUCERIN.
About Dr.Tasneem F. Mohammad, MD FAAD
Dermatologist, Detroit, MI
Tasneem F. Mohammad, MD FAAD is a Staff Physician in the Henry Ford Health System Department of Dermatology in Detroit, MI where she also completed her residency training and a photomedicine and pigmentation research fellowship. Her clinical and research interests include photomedicine, vitiligo, and pigmentary disorders. She has served on various committees for the Global Vitiligo Foundation, Skin of Color Society, and American Academy of Dermatology.
About Dr. Jennifer Beecker MD, FRCPC, CCFP(EM), DABD
Dermatologist, Ottawa, ON
Dr. Jennifer Beecker is a Royal College-certified dermatologist who is fully trained and certified in three separate medical specialties: Dermatology, Emergency Medicine and Family Medicine. In addition, she has earned American board-certification as a dermatologist by the American Board of Dermatology. Dr. Beecker is an active Staff Dermatologist at The Ottawa Hospital and Assistant Professor at the University of Ottawa. The range of conditions in which Dr. Beecker holds expertise includes medical dermatology, skin cancer, as well as cosmetic dermatology.
Dr. Beecker is a national expert in skin cancer detection and prevention. Dr. Beecker founded the Melanoma and Pigmented Lesion Clinic at The Ottawa Hospital academic teaching centre. She is the only dermatologist in Canada using this specialized equipment at a teaching hospital. Dr. Beecker trains medical residents and medical students in this clinic, as well as in general dermatology clinics. She is also Vice-Chair of the Dermatology Examination Committee at the Royal College of Physicians and Surgeons of Canada, which sets and conducts the exam for dermatology residents graduating and attempting to obtain Canadian certification as a dermatologist.
As Research Director for the Division of Dermatology at The Ottawa Hospital and a Clinical Investigator in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute (OHRI), Dr. Beecker conducts and supervises many research studies, and has multiple publications in the medical literature. She is invited to lecture about dermatology locally, nationally, and internationally, and is frequently interviewed by the media, especially on topics such as sun protection and skin cancer. In 2020, Dr. Beecker was awarded the prestigious “President’s Cup Award” by the Canadian Dermatology Association for the second time having also received this award in 2016. She is now President Elect of the Canadian Dermatology Association.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🔍Welcome back to Part 2 of our dialogue with Skin and Joint Podcast EADV Ambassador, Dr.Melinda Gooderham, where we delve deep into the groundbreaking advancements in treating chronic hand eczema, featuring the innovative pivotal trials and their implications for care.
Are we entering a new era for care for our patients with chronic hand eczema?Making her guest hosting debut on the Podcast, Dr. Jessica Asgarpour joins us for PART 2.
🆕Key Highlights we take a look at in PART 2:
Exploring New Agents in Chronic Hand Eczema Treatment (Efficacy Perspectives and Quality of Life Measures):
Dr. Gooderham offers an in-depth analysis of delgocitinib cream, a new topical for CHE.Delta 1 and Delta 2 trials focus on efficacy and safety Outcomes in terms of the Hand Eczema Area and Severity Index (HEXI) and DLQI scores.Safety Profile of Topical JAK inhibitors:
Patient Adherence and Formulation Challenges The role of delgocitinib as a non-steroidal option in treating hand eczema.Discussion on the evolving landscape of dermatological treatments and patient access to new therapies
Episode supported by an IME Grant from LEO Pharma
ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)
Toronto, ON
Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.
About Dr.Jessica Asgarpour, MD, FRCPCDermatologist | TorontoDr. Jessica Asgarpour is a Canadian and American board-certified dermatologist. She completed her medical school at the Cumming School of Medicine, in Calgary, Alberta, where she was born and raised. She went on to the University of Alberta for her residency training in dermatology, where she acted as co-chief resident from 2019-2020, and was awarded the Dr. Andrew Lin Dermatology Scholar award. She has also been awarded multiple scholarships to conferences to keep her up-to-date with the ever changing medical literature.
She has published in many peer-reviewed journals, and practices medicine with this same evidence-based approach. She practices medical, surgical and cosmetic dermatology. When she is not practicing dermatology, she enjoys keeping active and loves to run, spin and hike.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🐻Got lost in a labyrinth, found a bear, and almost became a rock star! 🐻⛏️
This week’s drop on the Skin and Joints Podcast PART 1 is a wild ride - from mistaking a geology conference for a dermatology one, to navigating Messe’s maze-like corridors. Ever wondered if ‘Messe’ stands for ‘mess’ or ‘maze’?
Join Dr. Melinda Gooderham, our Skin and Joints Podcast EADV Ambassador, as we uncover the hilarious journey at the EADV Berlin.Making her guest hosting debut on the Podcast, Dr. Jessica Asgarpour joins us to share tales from her world travels and EADV.
EADV 2023 Conference Debrief: Dr. Melinda Gooderham shares her unique insights from the EADV conference in Berlin, adding a layer of global expertise to the conversation.Cultural and Culinary Delights: From the historic streets of Berlin to the culinary adventures, the podcast paints a vivid picture of the experiences beyond the conference hallsChronic Hand Eczema (CHE) Insights: An enlightening conversation about CHE, a troublesome condition affecting many, characterized by itchiness, pain, and a significant impact on quality of life. A deep dive into the existing approaches to managing CHE, outlining their limitations and the need for more effective, long-term solutions.Breaking News from EADV: A new tool in the toolkit-delgocitinib's promising results in the DELTA 1 and 2 trials for CHE.
Spoiler alert: it involves accidental geology lectures and statue selfies! 🗺️
Tune in for an episode that’s more twisty than our conference’s hallways:
Other PART 1 Highlights of the Episode:
Four-Year Triumph with tralokinumab, data on Nemolizumab for treating pruritus in atopic dermatitis, psoriasis breakthroughs - oral peptides and more, foam home advantage for scalp and body psoriasis and weighty matters in psoriasis treatment
Episode supported by an IME Grant from LEO Pharma
ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)
Toronto, ON
Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.
About Dr.Jessica Asgarpour, MD, FRCPCDermatologist | TorontoDr. Jessica Asgarpour is a Canadian and American board-certified dermatologist. She completed her medical school at the Cumming School of Medicine, in Calgary, Alberta, where she was born and raised. She went on to the University of Alberta for her residency training in dermatology, where she acted as co-chief resident from 2019-2020, and was awarded the Dr. Andrew Lin Dermatology Scholar award. She has also been awarded multiple scholarships to conferences to keep her up-to-date with the ever changing medical literature.
She has published in many peer-reviewed journals, and practices medicine with this same evidence-based approach. She practices medical, surgical and cosmetic dermatology. When she is not practicing dermatology, she enjoys keeping active and loves to run, spin and hike.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🎙️🎙️ Dr. Lauren Lam joins us LIVE from the World Congress of Dermatology in Singapore! Dive into our Crazy Rich Asians-style adventures, unpack the future of AI in dermatology, and get the inside scoop on the latest was we think about HS (hidradenitis suppurtiva) 💡
Dive into Dr. Lam's Singaporean escapades! 🇸🇬What's the next big thing for HS treatment? 🧐How might AI revolutionize medical writing? ✍️Bonus: Have you heard of the Triple Threat yet?From mirage-like mansions to cutting-edge derm findings, join us for a roller coaster of insights, anecdotes and unscripted, unfiltered (maybe somewhat savage) moments.
Let Dr. Lam lead you through an unforgettable journey at the crossroads of dermatology, tech, and an unforgettable experience 🌟
EPISODE Supported by Pfizer.
ABOUT Dr. Lauren Lam BScH, MD, FRCPC Medical, Surgical & Cosmetic Dermatologist Calgary,AB
Clinical Lecturer | Division of Dermatology, Department of Medicine | University of Alberta
Dr. Lam is a Canadian board-certified dermatologist. She completed her medical school training at the University of Calgary & her dermatology residency at the University of Alberta. Since graduating, Dr. Lam has become a Clinical Lecturer with the University of Alberta. Her particular passions in dermatology are acne & hidradenitis suppurativa deroofings.
In addition to her regular practice, she volunteers on overseas medical trips. Her passion for providing care for under-served populations has taken her to Nunavut & rural Fiji. Outside of medicine, Dr. Lam is a proud aunt to 4 dogs, culinary enthusiast & international explorer.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🎙️🍫 Our Convo with Dr.Jerry TAN on Acne, Sun, Shades of Brown, and Identity 🌞🎨
🎙✈️ From a surprise detour in Toronto to runway rendezvous at the world’s best shopping airport. Join us for Dr. Jerry Tan’s deep dive into what's new in the world of acne
🌍✨Skin and Joints Podcast Dermatologist expert Dr.Jerry Tan untangles the intricate threads of identity. What do we say when someone asks about our ethnicity or race in an ever-mixed global landscape??🎨 Sick of the phototype jargon? Dive into a refreshing conversation where we shift from shades of grey to exploring every shade of brown 🎨
🌞🧴 And yes, don’t forget your sunscreen, no matter your shade!
#SkinAndJointsPodcast #WorldCongressOfDermatology #ShadesOfBrown #BeyondLabels #SunProtectionForAll
P.S. Spoiler Alert: Jet engines might be involved. 📍✈️😉
EPISODE Supported by BAUSCH HEALTH.
About Dr. Jerry Tan
Dermatologist, Windsor, ON
Dr. Tan received his medical degree from Queen’s University in Kingston, Ontario and trained in internal medicine at the University of Toronto and in dermatology at University of British Columbia and University of Michigan. His general dermatology and aesthetic dermatology practices are in Windsor Ontario Canada. He conducts clinical trials research at Windsor Clinical Research, a clinical trials site in dermatology. Aside from industry grants, he has received research funding from the Canadian Dermatology Foundation and the National Institutes of Health Research.
Research focus includes acne, acne scars and rosacea. Additional interests include outcome measurements and informed shared decision making in dermatology.
Dr. Tan chairs the working group on clinical practice guidelines of the Canadian Dermatology Association, the rosacea international consensus group (ROSCO) and the acne core outcomes research network (ACORN). He has been an associate editor of the Journal of the American Academy of Dermatology and the British Journal of Dermatology. Over the past 3 decades, Dr. Tan has authored/co-authored more than 100 peer-reviewed publications.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
-
🔊🎧 🎙️ What's New in PsO TX: My Real World Experience with Bimekizumab PART 2 🔊🎧
🎙️🩺🔍 Age-defying Dr.Marni Wiseman journeys with us through 22 years in #dermatology, spilling the secrets of revolutionary treatments and today's #psoriasis patient journeys.
🔊🎧 From the evolution of 1st gen biologic therapy to the latest data around Bimekizumab and it's role, we dive into a fresh discussion about Dr.Wiseman's secret sauce when it comes to treating plaque #psoriasis.
🔊🎧Hear about her initial approach to biologic naïve patients to determine suitability for biologic therapy.
Don't let PART 2 be skin deep; dive right in! 🎙️🩺🔍
In PART 2 we explore:
We deep dive into the real world experience with Dr. Wiseman who brings clarity to the use of Bimekizumab and other molecules in treating moderate to severe plaque psoriasisThe convenience of Bimekizumab's dosing schedule, its tolerability, and its significant impact on patient-reported outcomes and quality of life. Dr. Wiseman provides a comprehensive view on managing treatment accessibilityand coverage in different Canadian provinces, and nuances in coverage and criteria for accessing Bimekizumab.Dr. Wiseman's approach to baseline workups for patients, emphasizing the importance of screening for comorbidities like psoriatic arthritis and her anticipations for Bimekizumab's expanding indications. She also sheds light on new developments in treating Hidradenitis Suppurativa (HS) with Bimekizumab, based on recent clinical trial data.Join us for a masterclass in understanding and managing psoriasis with Dr. Marni Wiseman on the podcast.
🎙️Spoiler alert: Not all IL-17 inhibitors are created equal! And if you're itching (pun intended) to learn about that one Bimekizumab side effect everyone's talking about and the real world experience, tune in!
#DermTalks #Derm #MedicineMeetsManagement #BehindTheStethoscope #HealthcareDeepDive #PatientCareFirst #PracticePerfect #SkinAndSystems #DoctorDiaries #ClinicCheckup #HealthcareHacks #OptimizedOutcomes #DermDeepDive
Only on the Skin and Joints Podcast !
▶️Episode supported by UCB.
ABOUT Dr.Marni Wiseman MD FRCPC
Dr. Marni Wiseman began her Dermatology practice in Winnipeg, Manitoba in 2001. In addition to her teaching responsibilities as an Associate Professor and Section Head of Dermatology in the Faculty of Medicine at the University of Manitoba, Dr. Wiseman is the Medical Director of SKiNWISE DERMATOLOGY where she is involved in a general dermatology practice.
Dr. Wiseman’s areas of interest include psoriasis, atopic dermatitis, hidradenitis suppurativa, acne, and aesthetic dermatology. She actively participates in clinical trials through Wiseman Dermatology Research, where she has participated in over a hundred clinical trials. Dr. Wiseman is a frequent supervisor and mentor for medical students and residents. She has extensively published in areas of inflammatory skin disease, photodermatosis, and cutaneous malignancy.
Her community commitments are extensive and include involvement with the Canadian Dermatology Association as Provincial Director of the National Sun Awareness Program. She is an editor of the Journal of Cutaneous Medicine and Surgery, and was the chair of the Skin Cancer Disease Site Group at CancerCare Manitoba for 15 years. Dr. Wiseman does regular outreach skin cancer screening clinics in rural locations of Manitoba, has been featured in many news stories, and regularly presents at meetings and congresses nationally and internationally.
📻www.skinandjoints.ca
-
🛍️ Mall Maze Misadventures in Singapore 🛍️
🚨🔄Skin and Joints PodcastFaculty Dr. Melinda Gooderham: Dermatologist by day, unintentional mall explorer by... also day. 😂
Circling for hours, getting acquainted with that same pesky roundabout, and yet always ending up at square one – all within a stone’s throw of her hotel.
Could it be strategic design? 🤔 Or perhaps the universe’s way of reminding us that not all shortcuts turn out short. Or maybe just the irresistible allure of Singapore’s shopping havens? 🌆A chic linen suit, anyone? 🌸👗
🎙️ Tune in to hear Dr.Gooderham’s Singapore Story only on the Skin and Joints PodcastLive from the 25th World Congress of Dermatology in Singapore.
Episode supported by an IME Grant from Pfizer
#MallMisadventures#SingaporeStories#DermatologyDiaries#WCD🌏🎧
ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)
Toronto, ON
Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.
📻www.skinandjoints.ca
📻www.skinandjoints.ca
- Näytä enemmän
